
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Endoscopic Ultrasound (EUS) is a sophisticated medical imaging technique that combines endoscopy and ultrasound to provide detailed visual and diagnostic information about various internal organs and tissues. It has emerged as a powerful tool in modern medicine, allowing medical professionals to obtain high-resolution images from within the body, aiding in the diagnosis, staging, and treatment of a wide range of medical conditions.
EUS involves the use of a specialized endoscope, which is a thin, flexible tube with a light source and a small ultrasound transducer at its tip.The endoscope can be inserted into various body cavities, such as the esophagus, stomach, or rectum, depending on the target area. As the endoscope is carefully maneuvered through these passages, the ultrasound transducer emits high-frequency sound waves that are transmitted into the body.
These sound waves then bounce back after encountering different tissues and structures within the body. The ultrasound transducer captures these echoes, and a computer processes the information to generate real-time images. This allows medical professionals to visualize the layers of the gastrointestinal (GI) tract and adjacent structures with remarkable clarity.
EUS provides valuable insights into the composition, thickness, and consistency of tissues, aiding in the identification of abnormalities or lesions.One of the key advantages of EUS is its ability to provide highly detailed images of structures that are challenging to visualize using traditional imaging techniques.For instance, EUS is particularly useful in examining the pancreas and bile ducts, where conventional imaging methods often fall short due to their location deep within the body.
EUS allows for early detection and accurate diagnosis of pancreatic tumors, cysts, and other abnormalities, contributing to better patient outcomes. Furthermore, EUS plays a crucial role in cancer staging.It allows medical professionals to assess the extent of tumor growth, infiltration into nearby tissues, and involvement of lymph nodes.
This information is essential for determining the appropriate treatment plan, whether it involves surgery, radiation therapy, chemotherapy, or a combination of these approaches. In addition to its diagnostic capabilities, EUS also has therapeutic applications. EUS-guided fine-needle aspiration (FNA) and fine-needle biopsy (FNB) are procedures that can be performed during EUS to collect samples from suspicious lesions.
These samples are then examined under a microscope to determine their nature, whether benign or malignant. EUS-guided interventions can also include draining fluid collections, injecting medications, and placing stents to relieve obstructions in the GI tract.EUS has evolved over the years with the introduction of advanced technologies.
One notable advancement is the development of linear array endoscopes, which provide 360-degree ultrasound imaging.This allows for more comprehensive visualization of structures and enhances the accuracy of procedures. Additionally, the integration of Doppler ultrasound in EUS enables assessment of blood flow within vessels, aiding in the evaluation of blood supply to tumors and other tissues.
In summary, Endoscopic Ultrasound (EUS) is a cutting-edge medical imaging technique that combines endoscopy and ultrasound to provide detailed and real-time images of internal organs and tissues.
It is invaluable in diagnosing and staging a wide range of medical conditions, particularly those related to the gastrointestinal tract and adjacent structures. EUS offers advantages in early detection, accurate diagnosis, and effective treatment planning, making it an indispensable tool in modern medical practice. As technology continues to advance, EUS is likely to further refine its capabilities, contributing to improved patient care and outcomes.
The Global Endoscopic Ultrasound Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Fujifilm Sonosite Echo Navigator ESUS System: This system was launched in 2022 and is the first EUS system to offer both radial and linear scanning capabilities. This makes it a more versatile tool for EUS procedures, as it can be used to image a wider range of organs and tissues.
The Echo Navigator ESUS System also features a number of other advanced technologies, such as a high-definition display and a powerful processor, which provide improved image quality and performance. Olympus EUS Fine Needle Aspiration (FNA) Needle: This needle was launched in 2022 and is designed for use with EUS FNA procedures.
It has a number of features that make it ideal for this purpose, such as a sharp tip that minimizes tissue trauma, a side port for irrigation, and a large lumen that allows for the aspiration of larger samples.The Olympus EUS FNA Needle also features a number of safety features, such as a depth stop and a needle guard, which help to prevent complications during the procedure.
Hitachi UH7500 Endoscopic Ultrasound System: This system was launched in 2023 and is the latest in Hitachi's line of EUS systems. It features a number of new technologies, such as a high-frequency transducer that provides improved image resolution, and a real-time 3D imaging mode that allows for better visualization of complex structures.
The UH7500 also features a number of ergonomic improvements, such as a lighter weight and a more compact design, which make it easier to use for long procedures.
GE Healthcare ACUSON SC200 Endoscopic Ultrasound System: This system was launched in 2023 and is designed for use in a variety of EUS applications, including FNA, biopsy, and drainage.It features a number of advanced technologies, such as a high-definition display, a powerful processor, and a variety of transducers that can be used to image different organs and tissues.
The ACUSON SC200 also features a number of safety features, such as a depth stop and a needle guard, which help to prevent complications during the procedure.
Company | Product | Date | Description |
FUJIFILM India Private Limited | PB2020-M2 | 2023 | A compact ultrasonic probe system that can provide real-time ultrasound imaging of peripheral lung lesions. The system is lightweight, user-friendly, and can produce high-resolution ultrasonic images. It has an outer diameter of 1.4â1.9 mm and a working length of 2,150 mm, and can easily pass through a 2 mm working channel bronchoscope. |
Olympus Corporation | EU-ME3 | 2022 | The EU-ME3 is built to support more accurate diagnosis and treatment of hepatobiliary-pancreatic and lung diseases |
Sonoscape | Echoendoscope EG-UC5T
| 2021 | EG-UC5T Linear-Array echoendoscope that widens staging and therapeutic options. Combined with endorsed endoscope design, SonoScapeâs EG-UC5T fulfils and exceeds the most sought-after requirement from your medical team, levelling up the vision and achievement behind the wall of the GI tract. |
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |